KumarV,AbbasAK,FaustoN,AsterJC, 2014.,Pathologic basis of disease. 9th ed -
RosaiJ,AckermanLV, 2011.,Surgical pathology. 10th ed. Vol I. Missouri -
AtiqueM,AbbasiMS,JamalS,KhadimMT,AkhtarF,JamalN., 2014.CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder,J Coll Physiciains Surg Pak 24 351 -5
BabjukM,OosterlinckW,SylvesterR,KaasinenE,Paulo-RedortaJ, 2011.European association of urology (EAU). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update,Eur Urol 59 997 -1008
LeeJY,ChoKS,DiazRR,ChoiYD,ChoiHY, 2015.P53 expression as a prognostic factor in upper urinary tract urothelial carcinoma: A systematic review and meta-analysis,Urol Int 94 50 -7
2013.urinary bladder carcinoma,Indian J Pathol Microbiol 56 10 -5
SobinLH,WittekindC, 2002.,TNM classification of malignant tumors -
YildizIZ,RecavarrenR,ArmahHB,BastackyS,DhirR,ParwaniAV, 2009.Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in diagnosis of non-neoplastic and neoplastic bladder biopsies,Diagn Pathol 4 35 -
SunW,ZhangPL,HerreraGA, 2002.p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder,Appl Immunohistochem Mol Morphol 10 327 -31
PoletajewS,BiernackiR,BuraczynskiP,ChojnackiJ,CzarnackiJ,GajewskaD, 2016.Stage of bladder cancer in central Europe-Polish perspective,Neoplasma 63 642 -7
TunaB,YorukogluK,DuzcanE,SenS,NeseN,SariskB, 2011.Histological grading of papillary urothelial neoplasm: Impact of combined grading (two numbered grading system) on reproducibility,Virchows Arch 458 659 -64
SharmaP,KiniH,PaiRR,SahuKK,KiniJ, 2015.Study of the reproducibility of 2004 World Health Organization classification of urothelial neoplasms,Indian J Pathol Microbiol 58 59 -61
ComperatE,LarreS,RoupretM,NeuzilletY,PignotG,QuintensH, 2015.Clinicopathological charecteristics of urothelial bladder cancer in patients less than 40 years old,Virchows Arch 466 589 -94
NaeemA,NaseemN,AnwarS,ButtS,NagiAH, 2015.Clinicopathological pattern classification and staging of urinary bladder carcinomas - A five-year experience at a tertiary care hospital in central Punjab,J Ayub Med Coll Abbottabad 27 131 -4
Ying-YingWang,Jie-WeiChen,TaoQin, 2015.Bladder papillary urothelial neoplasm of low malignant potential in Chinese: A clinical and pathological analysis,Int J Clin Exp Pathol 8 5549 -55
LaishramRS,KipgenP,LaishramS,KhuraijamS,SharmaDC, 2012.Urothelial tumors of urinary bladder in Manipur: A histopathological perspective,Asian Pac J Cacer Prev 13 2477 -9
KawaguchiM,HaraN,BilimV,KoikeH,SuzukiM,KimTS, 2016.A diagnostic marker for superficial urothelial bladder carcinoma: Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression,BMC Cancer 16 805 -
BoegemannM,KrabbeLM, 2016.Prognostic implications of immunohistochemical biomarkers in non-muscle invasive bladder cancer and muscle-invasive bladder cancer,Mini Rev Med Chem -
StadlerWM,LernerSP,GroshenS,SteinJP,ShiSR,RaghavanD, 2011.Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status,J Clin Oncol 29 3443 -9
KoyuncuerA, .Immunohistochemical expression of p63, p53 in, -
BraitM,MunariE,LeBronC,NoordhuisMG,BegumS,MichailidiC, 2013.Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma,Cell Cycle 12 1058 -70
RoychowdhuryA,DeyRK,BandyapadhyayA,BhattacharyaP,MitraRB,DuttaR, 2012.Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder,J Indian Med Assoc 110 393 -6
HeF,MelamedJ,TangMS,HuangC,WuXR, 2015.Oncogenic HRAS activates epithelial to mesenchymal transition and confers stemness to p53-deficient urothelial cells to drive muscle invasion of basal subtypes carcinomas,Cancer Res 75 2017 -28
ZhouH,HeF,MendolsohnCL,TangMS,HuangC,WuXR, 2016.FGFR3b loop extracellular loop mutation lacks tumorigenicity in vivo but collaborates with p53/pRB deficiency to induce high grade papillary urothelial carcinoma,Sci Rep 6 25596 -